2009 H1N1 influenza prevention and treatment: counseling infertility patients.
It is known that pregnant women are at high risk for complications from the 2009 H1N1 influenza virus. Reproductive endocrinologists often have the opportunity to evaluate patients before conception and are able to counsel them before they become part of this high-risk obstetrics group. The 2009 H1N1 vaccine data and the current recommendations by the Centers for Disease Control and Prevention, American College of Obstetrics and Gynecology, and American Society of Reproductive Medicine are discussed. There is universal agreement in recommending vaccination for all pregnant women and all women attempting conception. Patients should be counseled regarding the vaccine and consider delaying conception until the immunization has been received.
Alford
Connie E
CE
Program in Reproductive and Adult Endocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, Maryland. Electronic address: alfordco@mail.nih.gov.
Chen
Grace L
GL
National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
Armstrong
Alicia Y
AY
Program in Reproductive and Adult Endocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, Maryland.
D002487:Centers for Disease Control and Prevention, U.S.; D000075202:Contraindications; D003376:Counseling / Q000379:methods*; D005260:Female; D006287:Health Planning Guidelines; D006801:Humans; D007246:Infertility / Q000628:therapy*; D053118:Influenza A Virus, H1N1 Subtype / Q000276:immunology; D007252:Influenza Vaccines / Q000627:therapeutic use*; D007251:Influenza, Human / Q000517:prevention & control*; D008297:Male; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000517:prevention & control; D014481:United States
D007252:Influenza Vaccines